Legal & General Group Plc

Position in GILD — Gilead Sciences, Inc.

CIK 764068 London, X0

Back to GILD Full portfolio

Position in GILD

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$1,458,491,578

+$192,107,759 QoQ

Shares Held

10,464,889

+1.4% QoQ

Ownership

0.843%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 93.33740663661125.ToString("F0")% Shared 0.ToString("F0")% None 6.662593363388757.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Legal & General Group Plc holds $25,087,571,930 across 12 Drug Manufacturers - General names. GILD ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	25,849,978	$5,098,132,659
2	LLY	ELI LILLY & Co	5,379,364	$4,947,777,626
3	JNJ	Johnson & Johnson	19,347,862	$4,729,391,386
4	ABBV	AbbVie Inc.	12,159,427	$2,644,553,777
5	MRK	Merck & Co., Inc.	19,538,545	$2,350,291,577
6	GILD	Gilead Sciences, Inc. This page	10,464,889	$1,458,491,578
7	AMGN	Amgen Inc	3,870,863	$1,361,963,146
8	PFE	Pfizer Inc	43,505,563	$1,221,636,207

All Filings in GILD

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,458,491,578	10,464,889	+1.4%	Shares	Defined	2026-05-08
2025-12-31	$1,266,383,819	10,317,613	+1.0%	Shares	Defined	2026-02-09
2025-09-30	$1,133,376,489	10,210,599	+4.2%	Shares	Defined	2025-11-13
2025-06-30	$1,086,098,595	9,796,145	-4.7%	Shares	Defined	2025-08-12
2025-03-31	$1,152,245,444	10,283,315	+3.8%	Shares	Defined	2025-05-15
2024-12-31	$915,500,406	9,911,231	-0.7%	Shares	Defined	2025-02-13
2024-09-30	$836,933,134	9,982,504	+0.3%	Shares	Defined	2025-02-28
2024-06-30	$683,180,712	9,957,451	-2.6%	Shares	Defined	2025-05-29
2024-03-31	$748,988,060	10,225,093	-1.4%	Shares	Defined	2025-05-29
2023-12-31	$839,745,445	10,365,948	-0.6%	Shares	Defined	2025-05-29
2023-09-30	$781,758,267	10,431,789	-3.6%	Shares	Defined	2023-11-14
2023-06-30	$833,826,571	10,819,081	+2.4%	Shares	Defined	2023-08-14
2023-03-31	$876,917,977	10,569,097	-1.1%	Shares	Defined	2023-05-15
2022-12-31	$917,463,754	10,686,823	-3.6%	Shares	Defined	2023-02-14
2022-09-30	$683,556,537	11,080,508	-2.3%	Shares	Defined	2022-11-14
2022-06-30	$701,313,999	11,346,287	-2.3%	Shares	Defined	2022-08-22
2022-03-31	$690,140,840	11,608,761	+7.7%	Shares	Defined	2022-05-16
2021-12-31	$782,492,700	10,776,652	-0.2%	Shares	Defined	2022-02-14
2021-09-30	$754,492,247	10,801,607	+4.9%	Shares	Defined	2021-11-15
2021-06-30	$709,094,801	10,297,630	+10.6%	Shares	Defined	2021-08-12
2021-03-31	$601,924,007	9,313,384	-0.5%	Shares	Defined	2021-05-17
2020-12-31	$545,578,565	9,364,548	+2.9%	Shares	Defined	2021-02-12
2020-09-30	$575,314,048	9,104,511	-0.5%	Shares	Defined	2020-11-13
2020-06-30	$703,924,059	9,149,000	+7.7%	Shares	Defined	2020-08-14
2020-03-31	$635,187,722	8,496,358	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.